Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Does it impact survival?
Washington - Sentinel lymph node biopsy may not be standard of care today in the management of patients with early melanoma and clinically negative nodes, but neither should it be considered an experimental technique, said Gary S. Rogers, M.D., at the annual meeting of the American Academy of Dermatology.
Recent Videos
Related Content
